Miura M
Second Department of Internal Medicine, Akita University School of Medicine, Japan.
Jpn Heart J. 1996 Sep;37(5):585-602. doi: 10.1536/ihj.37.585.
Endothelial driving factors pathophysiologically affect the regulation of coronary circulation. To investigate the regulation of vascular function by endothelium-derived relaxing factor (EDRF) and endothelial cells, endothelium-dependent relaxation impairment was studied in acute ischemia-reperfusion injury in large coronary artery and coronary microvasculature. EDRF (NO) production and release were inhibited due to ischemia-reperfusion injury to the endothelium of large coronary arteries. There was an increased sensitivity selective to ET-1 in large coronary arteries exposed to ischemia and reperfusion. Reduced endothelium-dependent relaxation and augmented ET-1 sensitivity in large coronary arteries suggest the existence of spasmogeneity in reperfused blood vessels. Ischemia and reperfusion also brought about various morphological and functional changes in the reperfused coronary microvasculature. Edema of perivascular interstitium and endothelial cells was the main observation and caused a decrease in the ability of the microvascular bed to dilate because of extravascular compression. To examine the long-term suppression of NO synthesis accompanying endothelial dysfunction, the long-term reactions of coronary arteries and myocardium due to chronic inhibition of NO synthesis by continuously infused L-NAME was investigated. Endothelial cell impairment, proliferation and disarrangement of medial smooth muscle cells, microvascular injury due to platelet thrombi and increased perivascular fibrous tissue were found in rat coronary arteries. Myocardial fibrosis due to coronary microvascular injury was observed. These changes in coronary arterial and myocardial structure were suppressed by ACE inhibitors. Therefore, ACE inhibitors are useful in the treatment of coronary microvascular impairments.
内皮驱动因子在病理生理上影响冠状动脉循环的调节。为了研究内皮源性舒张因子(EDRF)和内皮细胞对血管功能的调节,在大冠状动脉和冠状微血管的急性缺血再灌注损伤中研究了内皮依赖性舒张功能障碍。由于大冠状动脉内皮的缺血再灌注损伤,EDRF(一氧化氮)的产生和释放受到抑制。在经历缺血和再灌注的大冠状动脉中,对内皮素-1(ET-1)的敏感性增加。大冠状动脉中内皮依赖性舒张功能降低和ET-1敏感性增强表明再灌注血管中存在痉挛性。缺血和再灌注还导致再灌注冠状微血管出现各种形态和功能变化。血管周围间质和内皮细胞水肿是主要观察结果,由于血管外压迫导致微血管床扩张能力下降。为了研究伴随内皮功能障碍的一氧化氮合成的长期抑制,研究了连续输注L- NAME对一氧化氮合成的慢性抑制导致的冠状动脉和心肌的长期反应。在大鼠冠状动脉中发现了内皮细胞损伤、中层平滑肌细胞增殖和排列紊乱、血小板血栓导致的微血管损伤以及血管周围纤维组织增加。观察到冠状动脉微血管损伤导致的心肌纤维化。这些冠状动脉和心肌结构的变化被血管紧张素转换酶抑制剂所抑制。因此,血管紧张素转换酶抑制剂可用于治疗冠状微血管损伤。